Results 191 to 200 of about 8,113 (209)
Some of the next articles are maybe not open access.
Bosentan for chronic thromboembolic pulmonary hypertension
Expert Review of Cardiovascular Therapy, 2009Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe and underdiagnosed disease characterized by progressive hypertension secondary to organized thrombi in pulmonary vessels. The arteriolar lesions of CTEPH are similar to those seen in idiopathic pulmonary arterial hypertension (PAH).
Marco Confalonieri +3 more
openaire +3 more sources
La Revue de Médecine Interne, 2007
Resume L'ulcere digital est l'une des complications les plus douloureuses, les plus handicapantes et les plus difficiles a traiter de la sclerodermie systemique. Au cours de deux etudes randomisees contre placebo qui sont les plus importantes en nombre de patients dans cette pathologie, le bosentan, inhibiteur non selectif de l'endotheline 1, utilise
P.H. Carpentier, C. Francès
openaire +2 more sources
Resume L'ulcere digital est l'une des complications les plus douloureuses, les plus handicapantes et les plus difficiles a traiter de la sclerodermie systemique. Au cours de deux etudes randomisees contre placebo qui sont les plus importantes en nombre de patients dans cette pathologie, le bosentan, inhibiteur non selectif de l'endotheline 1, utilise
P.H. Carpentier, C. Francès
openaire +2 more sources
Bosentan for patients with chronic thromboembolic pulmonary hypertension
European Journal of Internal Medicine, 2009Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease leading to worsening functional status and reduced survival for those patients who cannot undergo pulmonary endarterectomy (PEA). Pharmacotherapy with novel drugs for pulmonary hypertension may be useful in treating patients who are poor candidates for surgery, but there are
Vassallo FG +8 more
openaire +4 more sources
Bosentan in mild pulmonary hypertension
The Lancet, 2008Konstantinos Dimopoulos +2 more
openaire +6 more sources
Bosentan for Pulmonary Hypertension
New England Journal of Medicine, 2002Brett N Pereira, Sundeep Salvi
openaire +3 more sources
Bosentan in Essential Hypertension
New England Journal of Medicine, 1998W. G. Haynes, David J. Webb, C. J. Ferro
openaire +3 more sources
Bosentan: profile report [PDF]
Drugs & Therapy Perspectives, 2003 Gideon Paul +2 more
openaire +1 more source
Ease Symptoms of Pulmonary Hypertension with Bosentan
The Nurse Practitioner, 2002Deborah Kupecz, Candace Berardinelli
openaire +3 more sources